Back to search

Article

An in silico reverse vaccinology approach to design a novel multiepitope peptide vaccine for non-small cell lung cancers

2023-01-01

Abstract excerpt

Non-small cell lung cancer (NSCLC) is the most prevalent and fatal lung cancer. The multiepitope vaccine is one of the immunotherapies successfully applied to treat NSCLC. We designed a multiepitope vaccine with MHC-I, MHC-II, CTL, and linear B cell epitopes of MAGE-A3, EGF, and MUC-1 oncoproteins employing in silico immunoinformatics approach. The structural assessment of the vaccine showed it as a well-stable pr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d92b533a-aa03-5aca-b247-0e05b747a78b
DOI
10.1016/j.imu.2023.101169
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An in silico reverse vaccinology approach to design a novel multiepitope peptide vaccine for non-small cell lung cancersDOI 10.1016/j.imu.2023.101169
Select a neighboring publication to make it the new centre.